Search

Alkermes PLC

Fechado

SetorSaúde

40.85 0.49

Visão Geral

Variação de preço das ações

24h

Atual

Mín

40.54

Máximo

42.11

Indicadores-chave

By Trading Economics

Rendimento

67M

501K

Vendas

103M

496M

P/E

Médio do Setor

116.263

55.725

EPS

0.52

Margem de lucro

0.101

Funcionários

2,050

EBITDA

76M

54M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+44.85% upside

Dividendos

By Acuity

Próximos Ganhos

27 de out. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-1.4B

7.4B

Abertura anterior

40.36

Fecho anterior

40.85

Sentimento de Notícias

By Acuity

50%

50%

118 / 339 Ranking em Healthcare

Alkermes PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de set. de 2026, 20:01 UTC

News

Alkermes Plc shares fell sharply as Goldman Sachs resumed coverage with a Neutral rating and a $50.00 price target, contributing to the stock's decline.

23 de set. de 2026, 20:07 UTC

Alkermes Plc shares fell sharply today, hitting a midday low and remaining below the 20-day moving average after earlier strength in the session.

22 de set. de 2026, 20:01 UTC

Event

Alkermes Plc reported positive results from a phase 1 study for ALKS 7290, yet shares fell sharply, remaining below their 20-day moving average.

21 de set. de 2026, 23:51 UTC

Event

Alkermes Plc's stock is declining in after-market trading despite positive phase 1 results for ALKS 7290, remaining below its 20-day moving average.

18 de set. de 2026, 20:02 UTC

Alkermes Plc shares fell sharply, reversing recent upward momentum, with a decline following a series of higher daily closes since Thursday's close.

17 de set. de 2026, 19:36 UTC

Alkermes Plc is trading higher, having previously peaked, but remains below its 20-day moving average and near the lower end of its one-month range.

15 de set. de 2026, 19:56 UTC

Alkermes Plc is trading higher today, with no specific news identified. Investor sentiment is influenced by expectations of a Federal Reserve rate hike.

14 de set. de 2026, 19:16 UTC

Alkermes Plc shares are lower amid negative market sentiment over inflation and supply chain issues, nearing the lower end of their one-month range.

11 de set. de 2026, 19:36 UTC

Alkermes shares are lower in Friday's session, lacking specific news. The broader market reacts to the Consumer Price Index release amid interest rate speculation.

10 de set. de 2026, 20:13 UTC

Alkermes Plc shares are lower in after-market trading, reflecting bearish sentiment amid the European Central Bank's interest rate hike and inflation concerns.

9 de set. de 2026, 20:07 UTC

Alkermes Plc shares are lower today, continuing a recent downward trend amid no specific news. The stock remains below its 20-day moving average.

8 de set. de 2026, 21:31 UTC

Alkermes Plc rose in after-market trading, gaining momentum despite broader market pressures and rising crude oil prices. No specific news was identified to explain the move.

4 de set. de 2026, 19:36 UTC

Alkermes Plc shares are lower amid broader market pressure from rising Treasury yields and expectations of tighter monetary policy from the Federal Reserve.

3 de set. de 2026, 22:01 UTC

Alkermes Plc shares are trading higher in after-market hours, amid a decline in ten-year Treasury yields that may be boosting overall market sentiment.

2 de set. de 2026, 21:01 UTC

Alkermes Plc's shares are lower in after-market hours, continuing a downward trend since Wednesday. The stock is near the lower end of its one-month range.

31 de ago. de 2026, 20:07 UTC

Alkermes shares are lower during Monday's session amid ongoing inflation concerns and expectations for a Federal Reserve interest rate hike.

28 de ago. de 2026, 22:36 UTC

Alkermes Plc shares are higher in after-market trading, following a notable increase earlier in the session. No specific news was identified to explain the move.

27 de ago. de 2026, 19:51 UTC

Alkermes Plc shares are lower amid significant downward pressure on biotechnology stocks. Earlier in the session, shares pulled back from a session high.

26 de ago. de 2026, 19:16 UTC

Alkermes Plc shares are lower today, reaching a session low earlier. No specific news was identified to explain the decline.

21 de ago. de 2026, 19:51 UTC

Alkermes Plc's shares are higher, supported by strong biotechnology sector momentum, though the stock is pulling back from earlier session highs.

20 de ago. de 2026, 20:01 UTC

Alkermes Plc shares are lower, impacted by broader weakness in the Biotechnology sector. The stock is trading below its 20-day moving average.

19 de ago. de 2026, 19:26 UTC

Alkermes Plc is trading higher, maintaining momentum since Tuesday's close, despite no specific news driving the price movement.

18 de ago. de 2026, 19:16 UTC

News

Alkermes Plc shares are lower after an insider sold 7,576 shares at prices between $49.19 and $49.65, raising investor concerns about the outlook.

17 de ago. de 2026, 23:31 UTC

Alkermes Plc shares are higher in after-market trading, reflecting a cumulative gain since Monday's close amid broader market volatility and fluctuating crude oil prices.

14 de ago. de 2026, 19:46 UTC

Alkermes Plc shares are lower today amid broader market weakness following a reported decline in U.S. retail sales for July.

13 de ago. de 2026, 19:26 UTC

Alkermes Plc shares are lower during Thursday's session, breaking a trend of higher closes. Broader market sentiment may be influenced by rising jobless claims.

12 de ago. de 2026, 21:51 UTC

Alkermes shares are higher in after-market trading, reflecting positive momentum amid easing inflation concerns and a broader market recovery.

11 de ago. de 2026, 19:26 UTC

Alkermes Plc shares are trading lower today, remaining near the lower end of their one-month range amid a lack of specific company news.

10 de ago. de 2026, 19:46 UTC

Alkermes shares are advancing today, despite earlier fluctuations and no specific news. Broader market uncertainty follows a decline in U.S. employment reported last Friday.

6 de ago. de 2026, 19:36 UTC

Alkermes Plc shares are lower today, reflecting unusual volatility and trading significantly below the 20-day moving average. No specific news was identified.

Comparação entre Pares

Variação de preço

Alkermes PLC Previsão

Preço-alvo

By TipRanks

44.85% parte superior

Previsão para 12 meses

Média 59.083 USD  44.85%

Máximo 83 USD

Mínimo 38 USD

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para Alkermes PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

13 ratings

9

Comprar

3

Manter

1

Vender

Sentimento

By Acuity

118 / 339 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Alkermes PLC

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.